Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy

Roberto Fogari, A. Zoppi, A. Mugellini, P. Preti, M. Destro, A. Rinaldi, G. Derosa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and

Original languageEnglish
Pages (from-to)680-695
Number of pages16
JournalAdvances in Therapy
Volume23
Issue number5
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Valsartan
Hydrochlorothiazide
Blood Pressure
Placebos
olmesartan

Keywords

  • Hydrochlorothiazide
  • Hypertension
  • Olmesartan
  • Valsartan

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{08052e4b138242d3bbe7773b010df5cc,
title = "Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy",
abstract = "This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and",
keywords = "Hydrochlorothiazide, Hypertension, Olmesartan, Valsartan",
author = "Roberto Fogari and A. Zoppi and A. Mugellini and P. Preti and M. Destro and A. Rinaldi and G. Derosa",
year = "2006",
month = "9",
doi = "10.1007/BF02850307",
language = "English",
volume = "23",
pages = "680--695",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Springer Healthcare",
number = "5",

}

TY - JOUR

T1 - Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy

AU - Fogari, Roberto

AU - Zoppi, A.

AU - Mugellini, A.

AU - Preti, P.

AU - Destro, M.

AU - Rinaldi, A.

AU - Derosa, G.

PY - 2006/9

Y1 - 2006/9

N2 - This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and

AB - This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and

KW - Hydrochlorothiazide

KW - Hypertension

KW - Olmesartan

KW - Valsartan

UR - http://www.scopus.com/inward/record.url?scp=33845602177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845602177&partnerID=8YFLogxK

U2 - 10.1007/BF02850307

DO - 10.1007/BF02850307

M3 - Article

C2 - 17142202

AN - SCOPUS:33845602177

VL - 23

SP - 680

EP - 695

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 5

ER -